Bharat Biotech to launch iNCOVACC-world's first nasal Covid vaccine
Image Credit: FPJ
Bharat Biotech's iNCOVACC, the world's first nasal COVID vaccine, has received approval; however, no efficacy data have been released as of yet. The needle-free intranasal Covid vaccine from Bharat Biotech has been approved for limited use in emergencies for people over the age of 18. It will be the world's first intranasal vaccine. The vaccine has been approved for use as both a primary series and a heterologous booster by theCDSCO.